Trump on Drugs & the Latest Healthcare News

Trump has been really feeling himself lately when it comes to one of the key pillars in his “affordability agenda” – prescription drug prices. At a press conference recently, he informed us that prescription drug prices were at their lowest point in 60 years, saying “ We went from the highest price for pharmaceuticals to the lowest.” If you’re feeling a little skeptical that Trump is our new healthcare champion, you aren’t alone! Today we’ve brought on an expert to unpack what Trump says he did, what he actually did, and whether that’s going to do anything to make your life easier! 

Plus, as always, we’ve got the latest healthcare news!

Podcast: Play in new window | Download

Subscribe: Youtube Music | More

Sarah Karlin-Smith is a research director for Public Citizen’s Access to Medicines Program. Her work explores how government policies and pharma industry lobbying influence how medicines are developed and approved, what diseases are prioritized by scientists, and who gets access to treatment and at what cost. She closely tracks and analyzes U.S. health policy impacting drug pricing, coverage, and reimbursement with the goal of advancing more equitable and fair pricing. She monitors activity in Congress, the courts, federal agencies such as the Centers for Medicare and Medicaid and the Federal Trade Commission, and state and local governments.

You can check out Public Citizen’s excellent article, “Four reasons Trump’s Drug Pricing Claims are Bogus” on their website!

Follow and support the pod!

Don’t forget to like this episode and subscribe to The Medicare for All Podcast on Apple Podcasts, Google Podcasts, or your favorite podcast platform!

This show is a project of the Healthcare-NOW Education Fund! Chip in here to support our work!